申请人:Institute of Organic Chemistry and Biochemistry of the Academy of
公开号:US05663159A1
公开(公告)日:1997-09-02
There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor agents.
本发明揭示了一种新的口服膦酸核苷类似物前药,其在生理条件下可水解为化合物,这些化合物可用作抗病毒剂,特别是对RNA和DNA病毒有效的药物。它们也可以用作抗肿瘤剂。